Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 59 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Desc)]
Φίλτρα: Συντάκτης is Papaefthymiou, Apostolis  [Clear All Filters]
2020
Doulberis, M., Papaefthymiou A., Polyzos S. A., Katsinelos P., Grigoriadis N., Srivastava D. S., et al. (2020).  Rodent models of obesity.. Minerva Endocrinol. 45(3), 243-263.
Doulberis, M., Polyzos S. A., Papaefthymiou A., Katsinelos P., Kiosses C., & Kountouras J. (2020).  Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents.. Expert Opin Pharmacother. 21(3), 247-251.
Kountouras, J., Gavalas E., Papaefthymiou A., Tsechelidis I., Polyzos S. A., Bor S., et al. (2020).  Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial.. Medicina (Kaunas). 56(7), 
Doulberis, M., Papaefthymiou A., Srivastava D. S., Exadaktylos A. K., Katsinelos P., Kountouras J., et al. (2020).  Update on the association between non-alcoholic fatty liver disease and Helicobacter pylori infection.. Int J Clin Pract. e13737.
2021
Papaefthymiou, A., Doulberis M., Karafyllidou K., Chatzimichael E., Deretzi G., Exadaktylos A. K., et al. (2021).  Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease.. Minerva Endocrinol (Torino).
Polyzos, S. A., Papaefthymiou A., Doulberis M., Mavridoglou G., & Kountouras J. (2021).  Helicobacter pylori infection and diabetes mellitus.. Diabetes Metab Syndr. 15(3), 845-846.
Doulberis, M., Pierre N. Thierry, Manzini G., Papaefthymiou A., Kountouras J., Klukowska-Rötzler J., et al. (2021).   Helicobacter pylori-Related Metabolic Parameters and Premalignant Gastric Mucosa Histological Lesions in Swiss Bariatric Patients.. Microorganisms. 9(7), 
Kountouras, J., Papaefthymiou A., Doulberis M., Polyzos S. A., Zavos C., Kazakos E., et al. (2021).  Impact of Helicobacter pylori-related Metabolic Syndrome and Gastroesophageal Reflux Disease on the Risk of Acute Myocardial Infarction.. J Neurogastroenterol Motil. 27(1), 147-148.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Deretzi G., Vardaka E., Soteriades E. S., et al. (2021).  Impact of -Related Metabolic Syndrome Parameters on Arterial Hypertension.. Microorganisms. 9(11), 
Kountouras, J., Papaefthymiou A., Polyzos S. A., Vardaka E., Boziki M., Kyriakopoulos A., et al. (2021).  Impact of -related Microbial Dysbiosis in the Pathogenesis of Metabolic Syndrome and Gastrointestinal Dysmotility Disorders.. J Neurogastroenterol Motil. 27(4), 653-654.
Papaefthymiou, A., Potamianos S., Goulas A., Doulberis M., Kountouras J., & Polyzos S. A. (2021).  Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents.. J Crohns Colitis.
Boziki, M., Polyzos S. A., Papaefthymiou A., Doulberis M., Bakirtzis C., Sintila S-A., et al. (2021).  Potential impact of Helicobacter pylori-related metabolic syndrome and Galectin-3 on liver, chronic kidney and brain disorders.. Metabolism. 154736.
Kountouras, J., Papaefthymiou A., Polyzos S. A., & Doulberis M. (2021).  A potential impact of Helicobacter pylori-related sarcopenia on severity of portal hypertension.. Liver Int.
Papaefthymiou, A., Christodoulidis G., Koffas A., Doulberis M., Polyzos S. A., Manolakis A., et al. (2021).  Role of autophagy in gastric carcinogenesis.. World J Gastrointest Oncol. 13(10), 1244-1262.
Boziki, M., Grigoriadis N., Papaefthymiou A., Doulberis M., Polyzos S. A., Gavalas E., et al. (2021).  The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis.. Neurochem Int. 144, 104938.
2022
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Tzitiridou-Chatzopoulou M., Chatzopoulos D., et al. (2022).  Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease.. Dig Dis Sci.
Rupp, S., Papaefthymiou A., Chatzimichael E., Polyzos S. A., Spreitzer S., Doulberis M., et al. (2022).  Diagnostic approach to -related gastric oncogenesis.. Ann Gastroenterol. 35(4), 333-344.
Kountouras, J., Doulberis M., Polyzos S. A., Kazakos E., Vardaka E., Tzitiridou-Chatzopoulou M., et al. (2022).  Emerging parameters relevant to the management of antimicrobial-resistant Helicobacter pylori infection.. Intern Med J. 52(9), 1654-1655.
Kountouras, J., Kazakos E., Polyzos S. A., Chatzopoulos D., Tzitiridou-Chatzopoulou M., Doulberis M., et al. (2022).  GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection.. Helicobacter. 27(3), e12884.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Vardaka E., Touloumtzi M., et al. (2022).  Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension.. Arq Bras Cardiol. 119(3), 502-504.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Vardaka E., Touloumtzi M., et al. (2022).  Letter to the Editor Regarding "The Association of Helicobacter pylori, Eradication, and Early Complications of Laparoscopic Sleeve Gastrectomy" by Abeid et al.. Obes Surg. 32(6), 2079-2080.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Tzitiridou-Chatzopoulou M., Chatzopoulos D., et al. (2022).  Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease.. Metabolism. 135, 155276.
Kountouras, J., Papaefthymiou A., Polyzos S. A., & Doulberis M. (2022).  Potential Impact of Helicobacter pylori Infection on Pancreatic Cancer Pathophysiology.. J Gastrointest Cancer.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kyrailidi F., & Doulberis M. (2022).  Potential impact of Helicobacter pylori-related metabolic syndrome on arterial hypertension outcomes.. Am J Hypertens.
Kountouras, J., Doulberis M., Polyzos S. A., Tzitiridou M., Chatzopoulos D., Gialamprinou D., et al. (2022).  A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery.. Gastrointest Endosc. 96(6), 1088-1089.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές